companies / auritecpharma-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 3,050,0003.0M | ○ |
|---|---|---|
| founded | 2003 | |
| hq | PASADENA, California, USA | |
| industry | unknown | |
| stage | null |
Pharmaceutical R&D company developing long-acting drug-delivery technologies for HIV prevention, contraception, and chronic-disease therapies. Targets global-health funders and partners working on HIV/AIDS, women's health, and adherence-sensitive chronic-disease therapies. Decade-plus track record formulating long-acting implants and depots that reduce dosing frequency.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2023-09-01 | grant | 3,000,0003.0M | null | ○ |
| fact | status | src |
|---|---|---|
| Grant, $3.0M | attributed | ○ |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-17provenance_existence: self-reported → sourced, WEB 2026-10-17 | provenance_existence | self-reported → sourced | WEB 2026-10-17 |
Records begin 2026-09-24. all_changes